La chaîne d'options affiche les données clés des options sur actions de Simpple à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Simpple..

Simpple (NASDAQ:SPPL) Stock, Chaîne d'Options

Simpple

Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software. The majority of its revenue is generated from the Robots segment.

Simpple Ltd

The Board of Directors approved an incremental $5 billion share repurchase authorization. With the addition of this new authorization, the company has $8.5 billion available under its share repurchase authorizations.&nbsp;

News

Buybacks

Marathon Petroleum Approved Incremental $5B Stock Buyback Authorization

Management

ADIL

Adial Pharmaceuticals Appoints Vinay Shah As Chief Financial Officer, Effective Nov. 16

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.verint.com%2F&amp;esheet=54147052&amp;newsitemid=20241105841152&amp;lan=en-US&amp;anchor=Verint%26%23174%3B&amp;index=1&amp;md5=cd382155b60eff877615bca4ef844957">Verint&#xAE;</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNT#NASDAQ">VRNT</a>), The CX Automation Company&#x2122;, today announced that a leading bank awarded Verint an $11 million contract for its AI-powered Agent Copilot Bot to assist 6,500 agents in their contact center.&#x2A;
The bank's contact center agents speak with customers for approximately 400 million minutes each year. The Verint AI-powered bot is designed to listen to these calls in the background and provide agents with real-time assistance, including coaching and guidance.
The bank conducted a pilot before awarding the contract and, based on the pilot result, the estimated annual savings from deploying the AI-powered bot is in the tens of millions of dollars.

Contracts

VRNT

Leading Bank Awards Verint $11M Contract For AI-Powered Agent Copilot Bot To Assist 6,500 Agents In Their Contact Center

WIIM

BEAM

Beam Therapeutics shares are trading lower in reaction to a report indicating a patient in the company's CRISPR-based sickle cell treatment trial died.

SPPL

SIMPPLE Outlines Plan To Regain Nasdaq Compliance, Including Potential Reverse Stock Split; Requests Hearing With Nasdaq To Seek Extension While Continuing Business Operations And Securing New Contracts

SI-BONE, Inc., (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIBN#NASDAQ">SIBN</a>), a&nbsp;Silicon Valley-based medical device company dedicated to providing surgical solutions for sacropelvic disorders, today announced that the Centers for Medicare &amp; Medicaid Services (CMS) has granted Transitional Pass-Through (TPT) payment status for the iFuse Bedrock Granite&#x2122; (Granite) system, used for pelvic fixation and sacroiliac joint fusion in conjunction with lumbar spinal fusion procedures, under the Medicare Hospital Outpatient Prospective Payment System. TPT payment status, which will be effective up to three years beginning January 1, 2025, allows patient access to new and innovative technology like Granite by providing an add-on payment to hospitals and ambulatory surgery centers supporting it.
As part of the TPT determination, CMS confirmed that a customary deduction from the add-on payment, known as a device offset, will not be applied to lumbar spinal fusion procedures involving pelvic fixation with Granite. This decision recognizes that Granite costs are not currently included in the existing facility payment amount for the procedures using this technology.

Biotech

General

SIBN

SI-BONE Receives Transitional Pass-Through Payment Status For iFuse Bedrock Granite System, Used For Pelvic Fixation And Sacroiliac Joint Fusion In Conjunction With Lumbar Spinal Fusion Procedures, Under The Medicare Hospital Outpatient Prospective Payment System

Simpple Ltd, A Leading Technology Provider Announced Its Plan To Regain NASDAQ Compliance

Guidance

BLDP

Ballard Power Systems Expects Revenue In 2024 To Be Weighted Towards Q4

The New York State Common Retirement Fund has significantly reduced its stake in Vistra Corp., according to a recent filing with the Securities &amp; Exchange Commission (SEC). This move was executed during the third quarter.
What Happened: The fund divested 43,440 shares, marking a 21.6% reduction in its Vistra Corp. holdings. Following this transaction, the fund retains 157,565 shares of the company&#8217;s stock, valued at $18,678,000 as per the latest SEC filing. This adjustment is part of the fund&#8217;s broader portfolio management strategy.
The change in the portfolio comes at a time when Vistra Corp&#8217;s year-to-date (YTD) returns have crossed 200%. As per Benzinga Pro, Vistra Corp was trading 0.24% higher on Tuesday during pre-market than its previous day close at $115.74.
See Also: <a href="https://www.benzinga.com/news/24/11/41705158/cathie-wood-says-trumps-ideas-on-eliminating-income-tax-and-imposing-tariffs-brings-back-vibes-of-ea?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Cathie Wood Says Trump&#8217;s Ideas On Eliminating Income Tax And Imposing Tariffs Brings Back Vibes Of &#8216;Early</a>
Why It Matters: Texas-based Vistra Corp. <a href="https://www.benzinga.com/insights/news/24/11/41715992/evaluating-vistra-against-peers-in-independent-power-and-renewable-electricity-producers-industry">stands as a major player</a> in the Independent Power and Renewable Electricity Producers industry. It is one of the largest power producers and retail energy providers in the U.S., especially after acquiring Energy Harbor in 2024. This acquisition expanded Vistra&#8217;s portfolio to include 41 gigawatts of nuclear, coal, natural gas, and solar power generation, alongside one of the world&#8217;s largest utility-scale battery projects.
Vistra&#8217;s retail electricity business serves approximately 5 million customers across 20 states, covering nearly a third of Texas&#8217;s electricity consumers. The company emerged as an independent entity in 2016 after the bankruptcy of Energy Future Holdings and further expanded by acquiring Dynegy in 2018.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/11/41705665/palantir-technologies-gears-up-for-q3-print-here-are-the-recent-forecast-changes-from-wall-streets-?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Palantir Technologies Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Top Analysts</a></li>
</ul>
Image via Midjourney
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noreferrer noopener">Pooja Rajkumari</a>

Equities

Markets

New York State Common Retirement Fund Pares Vistra Corp Stake After Shares Rally Over 200% This Year

Artelo Biosciences, Inc. (NASDAQ:<a href="https://www.benzinga.com/stock/ARTL#NASDAQ">ARTL</a>), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic and neurological conditions, today announced that ART26.12, the Company's lead clinical FABP inhibitor, has been accepted into the NIH Helping to End Addiction Long Term (HEAL) Initiative's Preclinical Screening Platform for Pain (PSPP).
The HEAL Initiative is an NIH-wide effort to accelerate scientific solutions to the overdose epidemic, including opioid and stimulant use disorders, and the crisis of pain. Launched in April 2018, the initiative is focused on improving prevention and treatment strategies for opioid misuse and addiction, and enhancing pain management. For more information, visit: <a href="https://www.globenewswire.com/Tracker?data=V0OIqyLfFcY5W7pjPpAuOgSxpFF0XIvawVscW4wbdwg7V_FhA3Ltt3AEUAniLYFzGCWmQxbGtaOlCTeoy9z_gw==">https://heal.nih.gov</a>.
The PSPP program, part of the NIH HEAL Initiative, evaluates non-opioid assets in a battery of established preclinical pain models. The PSPP program accepts small molecules, biologics,&nbsp;devices,&nbsp;or natural products for evaluation, from researchers in academia and industry worldwide. For more information, visit: <a href="https://www.globenewswire.com/Tracker?data=V0OIqyLfFcY5W7pjPpAuOlGjlyIIOqxGCXGg7oAt6Z8k_ceVEneHLI1vwxQ_6cUhkiltyTw8QQT1pV5d70643HL2HPZdhRFfxJaV9YNhfRmH9nfw_RF6CKHtAfA4IrI-OAUc2GDix2f8AgJTeD-gGsZnWraYf9DQLl_KK0KyPERmmZ2qiTanbmibjkbPuCBhaatGJ8TqR2NK9mw7c9BFBPeEx1kzbGwZK3J_7R1YWB0=">https://heal.nih.gov/research/preclinical-translational/screening-platform</a>.
The content of this press release is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

ARTL

Artelo Biosciences Announces Acceptance Of ART26.12 Into The National Institutes Of Health's Helping To End Addiction Long Term Initiative's Preclinical Screening Platform For Pain

MPLX

MPLX shares are trading higher. The company reported Q3 financial results.

TCMD

Tactile Systems Tech shares are trading lower after BTIG downgraded the stock from Buy to Neutral.

Ballard Power Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLDP#NASDAQ">BLDP</a>) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of $(0.13) by 423.08 percent. The company reported quarterly sales of $14.800 million which missed the analyst consensus estimate of $23.556 million by 37.17 percent. This is a 46.33 percent decrease over sales of $27.575 million the same period last year.

Earnings

Earnings Misses

Ballard Power Systems Q3 2024 GAAP EPS $(0.68) Misses $(0.13) Estimate, Sales $14.800M Miss $23.556M Estimate

UL Solutions shares are trading higher after the company reported better-than-expect Q3 financial results.

<a href="https://www.statnews.com/2024/11/05/patient-dies-sickle-cell-beam-therapeutics-crispr/?utm_campaign=rss" title="https://www.statnews.com/2024/11/05/patient-dies-sickle-cell-beam-therapeutics-crispr/?utm_campaign=rss">https://www.statnews.com/2024/11/05/patient-dies-sickle-cell-beam-therapeutics-crispr/?utm_campaign=rss</a>

Patient In Beam Therapeutics' CRISPR Trial For Sickle Cell Disease Dies From Likely Chemotherapy Complications; Early Signs Of Gene Editing Effectiveness Observed In Other Participants

PHUN

Phunware Names Rahul Mewawalla As Chairman Of The Board To Lead Growth And Innovation In AI, Predictive Analytics, And Cloud Services

Vaccinex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCNX#NASDAQ">VCNX</a>), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and neurodegenerative disease (NDD) through the inhibition of SEMA4D, today announced that it will present new biomarker data that neoadjuvant treatment with pepinemab enhanced the clinical activity of immune checkpoint inhibitors in poorly immunogenic, HPV-negative, head and neck cancer (HNSCC). In a presentation at Society for Immunotherapy of Cancer's Annual Meeting (SITC) on November 8th, Vaccinex will present data from the Phase 2 KEYNOTE-B84 study (NCT04815720) for treatment of recurrent and metastatic disease as well as an independent study evaluating neoadjuvant treatment of resectable HNSCC (NCT03690986) showing that pepinemab combination treatments appear to induce mature lymphoid aggregates correlating with clinical benefit within immunotherapy resistant tumor populations, including HPV-negative and PD-L1 low HNSCC.

VCNX

Vaccinex Reports Improved Immunity Correlating With Clinical Benefit Of Pepinemab Combination Treatment At Society For Immunotherapy Of Cancer's Annual Meeting

HC Wainwright &amp; Co. analyst Raghuram Selvaraju maintains Verona Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNA#NASDAQ">VRNA</a>) with a Buy and raises the price target from $36 to $42.

Price Target

Analyst Ratings

VRNA

HC Wainwright & Co. Maintains Buy on Verona Pharma, Raises Price Target to $42

JP Morgan analyst Matthew Boss maintains Dollar Gen (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) with a Neutral and lowers the price target from $97 to $82.

JP Morgan Maintains Neutral on Dollar Gen, Lowers Price Target to $82

Expeditors Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPD#NASDAQ">EXPD</a>) reported quarterly earnings of $1.63 per share which beat the analyst consensus estimate of $1.35 by 20.74 percent. The company reported quarterly sales of $3.000 billion which beat the analyst consensus estimate of $2.444 billion by 22.76 percent. This is a 36.99 percent increase over sales of $2.190 billion the same period last year.

Earnings Beats

EXPD

Expeditors Intl Q3 2024 GAAP EPS $1.63 Beats $1.35 Estimate, Sales $3.000B Beat $2.444B Estimate

IPO Roundup: Boundless Bio, NeOnc Technologies and more

FGEN, LEXX and SGLY among mid-day movers

CLRO, SELX among major tech gainers; SPPL, BCAN among losers

PRST, HEAR among major tech gainers; KPLT, PGY among losers

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!



Moving stocks are a bankruptcy filing, regulator approval, a public offering and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Spectaire (NASDAQ:<a href="https://investorplace.com/stock-quotes/spec-stock-quote/">SPEC</a>) stock is rocketing more than 111% on <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318405643&amp;type=PDF&amp;symbol=SPEC&amp;cdn=402f87b97cb330efbad1632693edb216&amp;companyName=Spectaire+Holdings+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-20">letter, settlement and asset purchase agreements</a>.</li>



<li>Trinity Place (NYSEMKT:<a href="https://investorplace.com/stock-quotes/tphs-stock-quote/">TPHS</a>) shares are soaring over 52% with heavy pre-market trading today.</li>



<li>DermTech (NASDAQ:<a href="https://investorplace.com/stock-quotes/dmtk-stock-quote/">DMTK</a>) stock is surging more than 45% <a href="https://finance.yahoo.com/news/dermtech-files-voluntary-chapter-11-120500056.html">despite a recent bankruptcy filing</a>.</li>



<li>Sarepta Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/srpt-stock-quote/">SRPT</a>) shares are gaining over 37% on <a href="https://www.marketwatch.com/story/sarepta-shares-soar-37-following-expanded-approval-for-elevidys-991d6de5?mod=home-page">expanded regulator approval</a>.</li>



<li>Kintara Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/ktra-stock-quote/">KTRA</a>) stock is increasing 27% with strong early morning trading.</li>



<li>Qualigen Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/qlgn-stock-quote/">QLGN</a>) shares are rising more than 16% with heavy trading today.</li>



<li>Unusual Machines (NYSEMKT:<a href="https://investorplace.com/stock-quotes/umac-stock-quote/">UMAC</a>) stock is climbing close to 16% despite a lack of news today.</li>



<li>Simpple (NASDAQ:<a href="https://investorplace.com/stock-quotes/sppl-stock-quote/">SPPL</a>) shares are jumping nearly 15% without any clear news today.</li>



<li>Lion Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/lghl-stock-quote/">LGHL</a>) stock is heading over 13% higher on Friday morning.</li>



<li>Solid Biosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/sldb-stock-quote/">SLDB</a>) shares are up more than 13% without any news to report.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Abacus Life (NASDAQ:<a href="https://investorplace.com/stock-quotes/abl-stock-quote/">ABL</a>) stock is diving over 23% after <a href="https://www.nasdaq.com/press-release/abacus-life-announces-pricing-public-offering-common-stock-2024-06-20">pricing a public offering</a>.</li>



<li>Psyence Biomedical (NASDAQ:<a href="https://investorplace.com/stock-quotes/pbm-stock-quote/">PBM</a>) shares are tumbling 20% on Friday morning.</li>



<li>Professional Diversity (NASDAQ:<a href="https://investorplace.com/stock-quotes/ipdn-stock-quote/">IPDN</a>) stock is taking a more than 18% beating with strong early morning trading.</li>



<li>Kaival Brands Innovations (NASDAQ:<a href="https://investorplace.com/stock-quotes/kavl-stock-quote/">KAVL</a>) shares are sliding over 17% on Friday morning.</li>



<li>QXO (NASDAQ:<a href="https://investorplace.com/stock-quotes/qxo-stock-quote/">QXO</a>) stock is dropping 16% today.</li>



<li>Reliance Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/reli-stock-quote/">RELI</a>) shares are falling more than 15% <a href="https://investorplace.com/2024/06/why-is-reliance-global-reli-stock-up-283-today/">after a recent rally</a>.</li>



<li>MGO Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/mgol-stock-quote/">MGOL</a>) stock is retreating over 14% <a href="https://investorplace.com/2024/06/why-is-mgo-global-mgol-stock-up-133-today/">following a rally yesterday</a>.</li>



<li>Cyclerion Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cycn-stock-quote/">CYCN</a>) shares are decreasing 14% this morning.</li>



<li>Perfect (NYSE:<a href="https://investorplace.com/stock-quotes/perf-stock-quote/">PERF</a>) stock is slipping more than 12% today.</li>



<li>Scinai Immunotherapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/scni-stock-quote/">SCNI</a>) shares close out our pre-market stock movers down over 11% today.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-june-21st/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Simpple Ltd. (SPPL) has released an update. SIMPPLE Ltd, a key player in facilities management technology, announces strategic leadership changes a...

SIMPPLE Ltd Announces Strategic Growth and Leadership

Simpple Ltd. (SPPL) has released an update. SIMPPLE Ltd., a tech innovator in facilities management, has announced the signing of several contracts...

SIMPPLE Ltd. Expands Reach in ANZ Markets

Simpple Ltd. (SPPL) has released an update. Singapore-based Simpple Ltd. has announced a significant $1.0 million sale of its innovative multifunct...

Simpple Ltd. Secures $1M Robot Deal in Asia

Simpple (SPPL) announced that on April 26, the Company received a letter from the Listing Qualifications staff of The Nasdaq Stock Market notifying...

Simpple receives Nasdaq Staff Determination Letter

Simpple fails to regain Nasdaq compliance

AIRG

BCAN

BLDE

BOLD

BTOC

CLRO

CRBU

CUPR

CYCN

DMTK

ELGP

FGEN

FORA

HEAR

HOLO

HRTG

IPDN

JUNE

KAVL

KPLT

KTRA

LEXX

LGCL

LGHL

MAMO

MGOL

MINM

MTRS

NMRA

NTHI

NWGL

NXTP

PACK

PERF

PGHL

PRST

QBTS

QLGN

RDDT

RELI

RERE

RGLS

RNLX

RYDE

SCNI

SELX

SGLY

SLDB

SMXT

SPEC

SRPT

TCBP

TPHS

UBXG

UMAC

VERI

VINC

XELA

XPDB

ZBAO

Press Releases

SIMPPLE LTD. Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

SIMPPLE Ltd Provides Update on New Leadership Initiatives and Progress

SIMPPLE Ltd. Announces New Contracts and Partnerships in Australia and New Zealand

SIMPPLE Ltd. Announces $1.0 Million Sale of Multi-functional Robots in Singapore, Malaysia, and Thailand

SIMPPLE LTD. Announces Receipt of Nasdaq Staff Determination Letter

SIMPPLE Ltd. Comments on Plan to Regain Nasdaq Compliance

Alta Equipment Group Inc. Class A Common Stock

Alta Equipment Group

BioNexus Gene Lab

BlueLinx Hldgs

Baiyu Holdings

Euro Tech Holdings Company Limited - Ordinary Shares

Euro Tech Hldgs

Custom Truck One Source, Inc. Common Stock

Custom Truck One Source

DXP Enterprises

EVI Industries

FGI Industries

Hudson Technologies

iPower

Karat Packaging

Lavoro

Multi Ways Holdings Limited Ordinary Shares

Multi Ways Holdings

Titan Machinery

Transcat

ZKH Group Limited American Depositary Shares, each representing thirty-five (35) Class A Ordinary Shares

ZKH Group

Comments

Simpple

Simpple (SPPL) Options

No option chain data available. Please try again later

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL